White Mark Andrew

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
White Mark Andrew's trades of Rocket Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-09 2025-04-09
PrS Proposed sale
77,148
455.64
US$3,374,393 		77,148 455.64 US$3,374,393
2025-02-21 2025-02-21
PrS Proposed sale
66,332
229.07
US$1,340,486 		66,332 229.07 US$1,340,486
2025-01-31 2025-01-31
PrS Proposed sale
10,160
175.10
US$3,640,183 		10,160 175.10 US$3,640,183
2024-11-04 2024-10-31
S Sale
3,080 -4.3%
16.63
US$51,205 		3,080 -4.3% 16.63 US$51,205
2024-10-31 2024-10-31
PrS Proposed sale
3,080
16.62
US$51,205 		3,080 16.62 US$51,205
2024-07-09 2024-07-08
S Sale
3,026 -4.0%
20.40
US$61,715 		3,026 -4.0% 20.40 US$61,715
2024-07-08 2024-07-08
PrS Proposed sale
3,026
20.39
US$61,714 		3,026 20.39 US$61,714
2024-04-10 2024-04-08
S Sale
12,532 -14.3%
24.64
US$308,763 		12,532 -14.3% 24.64 US$308,763
2024-04-08 2024-04-08
PrS Proposed sale
12,532
24.64
US$308,767 		12,532 24.64 US$308,767